• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伴有胃肠道受累的移植后淋巴细胞增生性疾病

Post-transplantation lymphoproliferative disorder with gastrointestinal involvement.

作者信息

Inayat Faisal, Hassan Ghias Ul, Tayyab Ghias Un Nabi, Saif Muhammad Wasif

机构信息

Allama Iqbal Medical College, Lahore, Pakistan (Faisal Inayat).

Ameer ud Din Medical College, Lahore, Pakistan (Ghias UI Hassan, Ghias Un Nabi Tayyab).

出版信息

Ann Gastroenterol. 2018 Mar-Apr;31(2):248-251. doi: 10.20524/aog.2018.0226. Epub 2018 Jan 8.

DOI:10.20524/aog.2018.0226
PMID:29507477
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5825960/
Abstract

Post-transplantation lymphoproliferative disorders (PTLDs) are lymphoid proliferations or lymphomas that are the second most common tumors in adult transplant recipients. Most cases of PTLD are attributed to Epstein-Barr virus, which induces B-cell proliferation and occurs in the setting of severe immunosuppression after solid organ or bone marrow transplantation. The disorder is seen in 1-3% of liver transplant recipients and has a variable presentation chronology. Herein, we chronicle a case of aggressive B-cell lymphoma (PTLD WHO class-3) presenting with isolated gastrointestinal involvement in an Epstein-Barr virus-negative patient with living-donor liver transplantation, 4 years after receiving the transplant. While typical symptoms may be elusive in the immunocompromised setting, clinicians should be vigilant for underlying PTLD with isolated gastrointestinal involvement. Prompt detection and characterization by endoscopic evaluation with biopsy should be particularly stressed in such patients.

摘要

移植后淋巴细胞增生性疾病(PTLD)是淋巴样增生或淋巴瘤,是成年移植受者中第二常见的肿瘤。大多数PTLD病例归因于爱泼斯坦-巴尔病毒,该病毒诱导B细胞增殖,发生在实体器官或骨髓移植后严重免疫抑制的情况下。这种疾病在1%至3%的肝移植受者中可见,其临床表现具有时间上的变异性。在此,我们记录了一例侵袭性B细胞淋巴瘤(PTLD WHO 3级)的病例,该病例表现为孤立性胃肠道受累,患者为接受活体供肝移植4年后的爱泼斯坦-巴尔病毒阴性患者。在免疫功能低下的情况下,典型症状可能难以捉摸,临床医生应警惕存在孤立性胃肠道受累的潜在PTLD。对于此类患者,应特别强调通过内镜评估加活检进行快速检测和特征描述。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5703/5825960/9fe8072dee26/AnnGastroenterol-31-248-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5703/5825960/ccb0755871ba/AnnGastroenterol-31-248-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5703/5825960/5bc4289f68a2/AnnGastroenterol-31-248-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5703/5825960/c2ce90db53cb/AnnGastroenterol-31-248-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5703/5825960/9fe8072dee26/AnnGastroenterol-31-248-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5703/5825960/ccb0755871ba/AnnGastroenterol-31-248-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5703/5825960/5bc4289f68a2/AnnGastroenterol-31-248-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5703/5825960/c2ce90db53cb/AnnGastroenterol-31-248-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5703/5825960/9fe8072dee26/AnnGastroenterol-31-248-g004.jpg

相似文献

1
Post-transplantation lymphoproliferative disorder with gastrointestinal involvement.伴有胃肠道受累的移植后淋巴细胞增生性疾病
Ann Gastroenterol. 2018 Mar-Apr;31(2):248-251. doi: 10.20524/aog.2018.0226. Epub 2018 Jan 8.
2
Role of Epstein-Barr virus status and immunophenotypic studies in the evaluation of exfoliative cytology specimens from patients with post-transplant lymphoproliferative disorders.爱泼斯坦-巴尔病毒状态及免疫表型研究在移植后淋巴增殖性疾病患者脱落细胞学标本评估中的作用
Cancer Cytopathol. 2016 Jun;124(6):425-35. doi: 10.1002/cncy.21694. Epub 2016 Mar 17.
3
A population-based study of 135 lymphomas after solid organ transplantation: The role of Epstein-Barr virus, hepatitis C and diffuse large B-cell lymphoma subtype in clinical presentation and survival.一项基于人群的实体器官移植后135例淋巴瘤的研究:爱泼斯坦-巴尔病毒、丙型肝炎及弥漫性大B细胞淋巴瘤亚型在临床表现和生存中的作用。
Acta Oncol. 2014 May;53(5):669-79. doi: 10.3109/0284186X.2013.844853. Epub 2013 Oct 28.
4
Analysis of Post-Transplant Lymphoproliferative Disorder (PTLD) Outcomes with Epstein-Barr Virus (EBV) Assessments-A Single Tertiary Referral Center Experience and Review of Literature.通过爱泼斯坦-巴尔病毒(EBV)评估分析移植后淋巴细胞增生性疾病(PTLD)的预后——一家三级转诊中心的经验及文献综述
Cancers (Basel). 2021 Feb 21;13(4):899. doi: 10.3390/cancers13040899.
5
Post-transplant lymphoproliferative disorder presenting with multifocal aggressive osseous lesions.移植后淋巴细胞增生性疾病伴多灶性侵袭性骨病变。
BJR Case Rep. 2018 Oct 2;5(1):20180045. doi: 10.1259/bjrcr.20180045. eCollection 2019 Feb.
6
Posttransplant lymphoproliferative disorder in a kidney-pancreas transplanted recipient: simultaneous development of clonal lymphoid B-cell proliferation of host and donor origin.肾胰联合移植受者的移植后淋巴细胞增生性疾病:宿主和供体来源的克隆性B淋巴细胞增殖同时发生。
Am J Surg Pathol. 2006 Jul;30(7):900-5. doi: 10.1097/01.pas.0000202165.67278.b3.
7
[Post-transplant lymphoproliferative disease in liver transplant recipients--Merkur University Hospital single center experience].[肝移植受者的移植后淋巴细胞增生性疾病——梅尔库大学医院单中心经验]
Acta Med Croatica. 2011 Sep;65 Suppl 1:37-43.
8
Epstein-Barr virus-associated T-cell lymphoma in solid organ transplant recipients.实体器官移植受者中的爱泼斯坦-巴尔病毒相关T细胞淋巴瘤
Biomed Pharmacother. 2001 Sep;55(7):366-8. doi: 10.1016/s0753-3322(01)00081-6.
9
Central Nervous System Involvement in Epstein-Barr Virus-Related Post-Transplant Lymphoproliferative Disorders after Allogeneic Hematopoietic Stem Cell Transplantation.异基因造血干细胞移植后 EBV 相关移植后淋巴增殖性疾病的中枢神经系统受累。
Transplant Cell Ther. 2021 Mar;27(3):261.e1-261.e7. doi: 10.1016/j.jtct.2020.12.019. Epub 2020 Dec 22.
10
Primary Cutaneous Polymorphic EBV-Associated Posttransplant Lymphoproliferative Disorder After a Renal Transplant and Review of the Literature.肾移植后原发性皮肤多形性EB病毒相关移植后淋巴增殖性疾病及文献综述
Am J Dermatopathol. 2015 Oct;37(10):790-4. doi: 10.1097/DAD.0000000000000272.

引用本文的文献

1
Post-Transplant Lymphoproliferative Disorder at the Porta Hepatis Causing Hepatic Artery Stenosis and Cholestasis.肝门部移植后淋巴组织增生性疾病导致肝动脉狭窄和胆汁淤积
Am J Case Rep. 2025 Jan 23;26:e945837. doi: 10.12659/AJCR.945837.
2
A pediatric case series of catastrophic gastrointestinal complications of posttransplant lymphoproliferative disease with increasing incidence, high association with coronavirus disease 2019, higher mortality, and a plea for early endoscopy to prevent late fatal outcome.儿童移植后淋巴组织增生性疾病灾难性胃肠道并发症的病例系列,发病率增加,与 2019 年冠状病毒病的关联性高,死亡率高,并呼吁尽早进行内镜检查以预防晚期致命后果。
J Med Case Rep. 2023 Sep 19;17(1):396. doi: 10.1186/s13256-023-04123-5.
3

本文引用的文献

1
Posttransplant Lymphoproliferative Disorder of the Small Bowel as an Unexpected Cause of Iron Deficiency Anemia Decades after Heart Transplantation.心脏移植数十年后,小肠移植后淋巴组织增生性疾病成为缺铁性贫血的意外病因。
ACG Case Rep J. 2017 Jul 5;4:e86. doi: 10.14309/crj.2017.86. eCollection 2017.
2
Response to Rituximab Induction Is a Predictive Marker in B-Cell Post-Transplant Lymphoproliferative Disorder and Allows Successful Stratification Into Rituximab or R-CHOP Consolidation in an International, Prospective, Multicenter Phase II Trial.利妥昔单抗诱导反应是 B 细胞移植后淋巴组织增生性疾病的预测标志物,并允许在一项国际性、前瞻性、多中心 II 期试验中成功分层为利妥昔单抗或 R-CHOP 巩固治疗。
J Clin Oncol. 2017 Feb 10;35(5):536-543. doi: 10.1200/JCO.2016.69.3564. Epub 2016 Dec 19.
3
Emerging roles of a chemoattractant receptor GPR15 and ligands in pathophysiology.
趋化因子受体 GPR15 及其配体在病理生理学中的新兴作用。
Front Immunol. 2023 Jun 30;14:1179456. doi: 10.3389/fimmu.2023.1179456. eCollection 2023.
4
Isolated Colonic Histoplasmosis in Patients Undergoing Immunomodulator Therapy: A Systematic Review.免疫调节剂治疗患者的孤立性结肠组织胞浆菌病:系统评价。
J Investig Med High Impact Case Rep. 2023 Jan-Dec;11:23247096231179448. doi: 10.1177/23247096231179448.
5
Early Onset Post-transplant Lymphoproliferative Disorder Presenting with Diarrhea Post-orthotopic Liver Transplant Treated Successfully with Single Rituximab Agent.早期移植后淋巴细胞增生性疾病表现为原位肝移植术后腹泻,单药利妥昔单抗成功治疗
Cureus. 2019 Nov 19;11(11):e6200. doi: 10.7759/cureus.6200.
Post-transplant lymphoproliferative disease (PTLD): risk factors, diagnosis, and current treatment strategies.移植后淋巴组织增生性疾病(PTLD):危险因素、诊断和当前治疗策略。
Curr Hematol Malig Rep. 2013 Sep;8(3):173-83. doi: 10.1007/s11899-013-0162-5.
4
Post-transplant lymphoproliferative disorder presented as small bowel intussusception in adult liver transplant patient.移植后淋巴组织增生性疾病在一名成年肝移植患者中表现为小肠套叠。
J Korean Surg Soc. 2012 Jan;82(1):50-3. doi: 10.4174/jkss.2012.82.1.50. Epub 2011 Dec 27.
5
Epidemiology of posttransplant lymphoproliferative disorders in adult kidney and kidney pancreas recipients: report of the French registry and analysis of subgroups of lymphomas.成人肾和肾胰腺移植受者移植后淋巴组织增生性疾病的流行病学:法国登记处的报告和淋巴瘤亚组分析。
Am J Transplant. 2012 Mar;12(3):682-93. doi: 10.1111/j.1600-6143.2011.03896.x. Epub 2012 Jan 6.
6
Risk factors for early-onset and late-onset post-transplant lymphoproliferative disorder in kidney recipients in the United States.美国肾移植受者中早发和晚发移植后淋巴组织增生性疾病的危险因素。
Am J Hematol. 2011 Feb;86(2):206-9. doi: 10.1002/ajh.21911.
7
Lymphoma after solid organ transplantation: risk, response to therapy, and survival at a transplantation center.实体器官移植后淋巴瘤:某移植中心的风险、对治疗的反应及生存情况
J Clin Oncol. 2009 Jul 10;27(20):3354-62. doi: 10.1200/JCO.2008.20.0857. Epub 2009 May 18.
8
Prospective study of sequential reduction in immunosuppression, interferon alpha-2B, and chemotherapy for posttransplantation lymphoproliferative disorder.免疫抑制、干扰素α-2B及化疗序贯减量治疗移植后淋巴细胞增生性疾病的前瞻性研究
Transplantation. 2008 Jul 27;86(2):215-22. doi: 10.1097/TP.0b013e3181761659.
9
Gastrointestinal involvement of posttransplant lymphoproliferative disorder in lung transplant recipients: report of a case.肺移植受者移植后淋巴细胞增生性疾病的胃肠道受累:一例报告
Dis Colon Rectum. 2005 Nov;48(11):2144-7. doi: 10.1007/s10350-005-0116-7.
10
Posttransplantation lymphoproliferative disorder: endoscopic findings.
J Pediatr Gastroenterol Nutr. 2000 Oct;31(4):458-61. doi: 10.1097/00005176-200010000-00026.